Abstract
Rho-associated protein kinase (ROCK), a molecular switch, modulates cellular functions in many cancers, such as hepatocellular, breast, colon cancers, etc. However, little is known the effect of ROCK on cell adhesion and mobility in esophageal squamous cell cancer (ESCC), one of the most diagnosed cancers in China. In this study, Y-27632 was used to specifically block ROCK activity in ESCC cells. Adhesion of ESCC cells was detected by homotypic and heterotypic adhesion assay together with examination of E-cadherin expression. Motility of ESCC cells changes were examined by detection of phosphorylated cofilin and observed under confocal microscopy, respectively. We found that Y-27632 increased both heterotypic and homotypic adhesion, and the expression of E-cadherin; decreased phosphorylated cofilin resulting in actin rearrangement in ESCC cells. All these findings indicate that ROCK signaling pathway plays an important role in cell adhesion and mobility, suggesting that it may be used as a potential target for therapy of ESCC.
Similar content being viewed by others
References
Ortíz-López L, Morales-Mulia S, Ramírez-Rodríguez G, Benítez-King G (2009) ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration. J Pineal Res 46:15–21
Leve F, de Souza W, Morgado-Díaz JA (2008) A cross-link between protein kinase A and Rho-family GTPases signaling mediates cell–cell adhesion and actin cytoskeleton organization in epithelial cancer cells. J Pharmacol Exp Ther 327:777–788
Lawler K, Foran E, O’Sullivan G, Long A, Kenny D (2006) Mobility and invasiveness of metastatic esophageal cancer are potentiated by shear stress in a ROCK- and Ras-dependent manner. Am J Physiol Cell Physiol 291:C668–C677
Nakagawa H, Yoshioka K, Miyahara E, Fukushima Y, Tamura M, Itoh K (2005) Intrathecal administration of Y-27632, a specific Rho-associated kinase inhibitor, for rat neoplastic meningitis. Mol Cancer Res 3:425–433
Shimada T, Nishimura Y, Nishiuma T, Rikitake Y, Hirase T, Yokoyama M (2007) Adenoviral transfer of rho family proteins to lung cancer cells ameliorates cell proliferation and motility and increases apoptotic change. Kobe J Med Sci 53:125–134
Rösel D, Brábek J, Tolde O, Mierke CT, Zitterbart DP, Raupach C, Bicanová K, Kollmannsberger P, Panková D, Vesely P, Folk P, Fabry B (2008) Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces. Mol Cancer Res 6:1410–1420
Xue F, Takahara T, Yata Y, Xia Q, Nonome K, Shinno E, Kanayama M, Takahara S, Sugiyama T (2008) Blockade of Rho/Rho-associated coiled coil-forming kinase signaling can prevent progression of hepatocellular carcinoma in matrix metalloproteinase-dependent manner. Hepatol Res 38:810–817
Vishnubhotla R, Sun S, Huq J, Bulic M, Ramesh A, Guzman G, Cho M, Glover SC (2007) ROCK-II mediates colon cancer invasion via regulation of MMP-2 and MMP-13 at the site of invadopodia as revealed by multiphoton imaging. Lab Invest 87:1149–1158
Lane J, Martin TA, Watkins G, Mansel RE, Jiang WG (2008) The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. Int J Oncol 33:585–593
Papadopoulou N, Charalampopoulos I, Alevizopoulos K, Gravanis A, Stournaras C (2008) Rho/ROCK/actin signaling regulates membrane androgen receptor induced apoptosis in prostate cancer cells. Exp Cell Res 314:3162–3174
Ordóñez-Morán P, Larriba MJ, Pálmer HG, Valero RA, Barbáchano A, Duñach M, de Herreros AG, Villalobos C, Berciano MT, Lafarga M, Muñoz A (2008) RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells. J Cell Biol 183:697–710
Ghosh K, Thodeti CK, Dudley AC, Mammoto A, Klagsbrun M, Ingber DE (2008) Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro. Proc Natl Acad Sci USA 105:11305–11310
Katiyar S, Hedau S, Jain N, Kar P, Khuroo MS, Mohanta J, Kumar S, Gopalkrishna V, Kumar N, Das BC (2005) p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett 218:69–79
Whibley CE, Keyzers RA, Soper AG, Davies-Coleman MT, Samaai T, Hendricks DT (2005) Antiesophageal cancer activity from Southern African marine organisms. Ann N Y Acad Sci 1056:405–412
Montesano R, Hollstein M, Hainaut P (1996) Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 69:225–235
Yoshii A, Iizuka K, Dobashi K, Horie T, Harada T, Nakazawa T, Mori M (1999) Relaxation of contracted rabbit tracheal and human bronchial smooth muscle by Y-27632 through inhibition of Ca2+ sensitization. Am J Respir Cell Mol Biol 20:1190–1200
Tian F, Zang WD, Hou WH, Liu HT, Xue LX (2006) Nuclear factor-κB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA. Acta Biochim Biophys Sin 38:318–326
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Hou GQ, Xue LX, Lu ZM, Fan TL, Tian F, Xue YL (2007) An activated mTOR/p70S6 K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR. Cancer Lett 253:236–248
Wang SM, Zhu J, Pan LF, Liu YK (2008) Inhibitory effect of dimeric β peptide on the recurrence and metastasis of hepatocellular carcinoma in vitro and in mice. World J Gastroenterol 14:3054–3058
Park TY, Park MH, Shin WC, Rhee MH, Seo DW, Cho JY, Kim HM (2008) Anti-metastatic potential of ginsenoside Rp1, a novel ginsenoside derivative. Biol Pharm Bull 31:1802–1805
Meyer-Ter-Vehn T, Gebhardt S, Sebald W, Buttmann M, Grehn F, Schlunck G, Knaus P (2006) p38 inhibitors prevent TGF-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci 47:1500–1509
Li Q, Mattingly RR (2008) Restoration of E-cadherin cell–cell junctions requires both expression of E-cadherin and suppression of ERK MAP kinase activation in Ras-transformed breast epithelial cells. Neoplasia 10:1444–1458
Muise AM, Walters TD, Glowacka WK, Griffiths AM, Ngan BY, Lan H, Xu W, Silverberg M, Rotin D (2009) Polymorphisms in E-cadherin (CDH1) result in a mis-localized cytoplasmic protein that is associated with Crohn’s Disease. Gut 58:1121–1127
Molina-Ortiz I, Bartolomé RA, Hernández-Varas P, Colo GP, Teixidó J (2009) Overexpression of E-cadherin on melanoma cells inhibits chemokine-promoted invasion involving p190RhoGAP/p120ctn-dependent inactivation of RhoA. J Biol Chem 284:15147–15157
Zhong XY, Zhang LH, Jia SQ, Shi T, Niu ZJ, Du H, Zhang GG, Hu Y, Lu AP, Li JY, Ji JF (2008) Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer. Histopathology 52:560–568
Pyo SW, Hashimoto M, Kim YS, Kim CH, Lee SH, Johnson KR, Wheelock MJ, Park JU (2007) Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome. J Craniomaxillofac Surg 35:1–9
Zhai B, Yan HX, Liu SQ, Chen L, Wu MC, Wang HY (2008) Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas. World J Gastroenterol 14:5665–5673
Filenius S, Tervo T, Virtanen I (2003) Production of fibronectin and tenascin isoforms and their role in the adhesion of human immortalized corneal epithelial cells. Invest Ophthalmol Vis Sci 44:3317–3325
Imamura F, Mukai M, Ayaki M, Akedo H (2000) Y-27632, an inhibitor of rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase. Jpn J Cancer Res 91:811–816
Han S, Ritzenthaler JD, Sitaraman SV, Roman J (2006) Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem 281:29614–29624
Gill KS, Beier F, Goldberg HA (2008) Rho-ROCK signaling differentially regulates chondrocyte spreading on fibronectin and bone sialoprotein. Am J Physiol Cell Physiol 295:C38–C49
Honjo M, Tanihara H, Kameda T, Kawaji T, Yoshimura N, Araie M (2007) Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery. Invest Ophthalmol Vis Sci 48:5549–5557
Jiang P, Enomoto A, Takahashi M (2009) Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton. Cancer Lett. doi:10.1016/j.canlet.2009.02.034
Wang W, Goswami S, Sahai E, Wyckoff JB, Segall JE, Condeelis JS (2005) Tumor cells caught in the act of invading: their strategy for enhanced cell motility. Trends Cell Biol 15:138–145
Acknowledgments
This study was supported by the grants from Key Programs of Science and Technology of Education Ministry of China (No. 00190) and the Tenth Five-Year Plan’s “211 Projects “of Education Ministry of China (No. 2002-2).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, L., Xue, L., Yan, H. et al. Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cells. Mol Biol Rep 37, 1971–1977 (2010). https://doi.org/10.1007/s11033-009-9645-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-009-9645-9